Three-Monthly Long-Acting Formulation of Paliperidone Palmitate is a Dominant Treatment Option, Cost Saving while Adding Qalys, Compared to the One-Monthly Formulation in the Treatment of Schizophrenia in Belgium- A Cost-Utility Study
Abstract
Authors
R De Moor B Malfait F Tedouri C De Vos C van Gils